ULACNet Update

Banner of the ULACNet Update

Subscribe to ULACNet Update.

2022

ULACNet Update
As we embark on year 4 of ULACNet, this issue highlights successes and opportunities, considers how we respond to the community voice in study recruitment, discusses community participation in ULACNet-201 trial recruitment in Mexico, and presents social media as a recruitment strategy for ULACNet-101.

(Delivered September 2022)

ULACNet-301 participant receiving first study vaccine.
In this issue, we feature: ULACNet Initiative to Enhance Community Dialogue (UNITED), Community outreach strategies for recruitment in ULACNet-101 in Puerto Rico, Accrual initiated in Peru for ULACNet-301, an Investigator Spotlight on Dr. Luisa Lina Villa, and an introduction to new DCP staff Dr. Silvina Frech.

(Delivered April 2022)

Partial screen grab of the ULACNet Zoom meeting showing a grid 9 participants.
This issue recognizes January as Cervical Cancer Awareness Month by presenting four articles entitled, "ULACNet Annual Meeting: A Global Network Together in One (Zoom) Room", "Perseverance Through the COVID Pandemic", "What’s In A Name?", and "Lessons Learned from ULACNet-101: Starting a Clinical Trial Amidst a Pandemic".

(Delivered January 2022)

2021

Group photo of CAMPO team.
In this issue, we feature: ULACNet-101 Getting Ready for Recruitment, ROCCHHA Opens Enrollment in Puerto Rico and Brazil for ULACNet-201, and an interview with Dr. Lenka Kolevic. Translations are available in Spanish and Portuguese.

(Delivered September 2021)

English

Welcome to ULACNet Update, your source for programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)!

ULACNet is an international collaborative research network with partner organizations in the US and Latin America and the Caribbean focused on developing evidence for human papillomavirus (HPV)-related cancer prevention in people living with human immunodeficiency virus (HIV).

ULACNet clinical trials explore research questions in three key areas:

  • optimizing dosing and delivery and evaluating new indications for HPV prophylactic vaccines;
  • evaluating new biomarkers and technologies for improving accuracy of cervical and anogenital cancer screening and triage; and
  • evaluating novel non-excisional treatments for HPV-related precancerous lesions.

Research from this network is expected to influence the development of clinical practice guidelines to improve preventive care and reduce the burden of HPV-related cancers in people living with HIV.

ULACNet Management Team

Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Vik is a Director of the ULACNet Program and Deputy Chief of Breast and Gynecologic Cancer Research Group.

Silvina Frech, Ph.D, M.S.
Silvina is a Program Director in the Breast and Gynecologic Cancer Research group with more than 20 years of experience in cancer research and control in low- and middle-income countries (LMICs).

Brandy Heckman-Stoddard, Ph.D., M.P.H.
Brandy is the chief of the DCP Breast and Gynecologic Cancer Research Group.

Emma Brofsky, M.S.P.H.
Emma is a Scientific Program Analyst with a strong background in public health and program management.

Margaret House, R.N., B.S.N.
Maggie is a Nurse Consultant in DCP with over 30 years of oncology nursing and clinical trials experience.

ULACNet Partnership Centers

ULACNet Partnership Centers: CAMPO, ROCCHHA, Colaboración Evita

Espa√Īol

Bienvenidos a ULACNet Update, donde compartiremos actualizaciones programáticas y de investigación de la Red de Ensayos Clínicos para la Prevención del VIH y el HPV en Estados Unidos, América Latina y el Caribe (ULACNet, US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network).

ULACNet es una red internacional de investigación colaborativa con organizaciones asociadas en los Estados Unidos y América Latina y el Caribe que se centra en el desarrollo de evidencia para la prevención del cáncer relacionado con el virus del papiloma humano (VPH) en personas que viven con el virus de inmunodeficiencia humana (VIH).

Los ensayos clínicos de la ULACNet estudian asuntos de investigación en tres áreas clave:

  • optimizar la dosificaci√≥n y la administraci√≥n y evaluar nuevas indicaciones para las vacunas profil√°cticas contra el VPH;
  • evaluar nuevos biomarcadores y tecnolog√≠as para mejorar la precisi√≥n del cribado y la selecci√≥n del c√°ncer cervical y de ano; y
  • evaluar nuevos tratamientos sin escisi√≥n para las lesiones precancerosas relacionadas con el VPH.

Esperamos que la investigación de esta red influya en el desarrollo de normas de prácticas clínicas para mejorar la atención preventiva y reducir la carga de los cánceres relacionados la VPH en personas que viven con VIH.

Equipo de Supervisores

Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Vik es director de la programa ULACNet y jefe adjunto del grupo de Investigación de Cáncer de Mama y Ginecológico que supervisa la investigación clínica de prevención del cáncer de cuello uterino y otros cánceres relacionados con el virus del papiloma humano (VPH).

Silvina Frech, Ph.D, M.S.
Silvina es Directora del Programa en el grupo de Investigaci√≥n de C√°ncer de Mama y Ginecol√≥gico con mas de 20 a√Īos de experiencia en investigaci√≥n y control del cancer en pa√≠ses de bajos y medianos ingresos.

Brandy Heckman-Stoddard, Ph.D., M.P.H.
Brandy es jefa del Grupo de investigación de cáncer de mamas y ginecológico del DCP.

Emma Brofsky, M.S.P.H.
Emma es una analista de programas cient√≠ficos con una amplia experiencia en salud p√ļblica y gesti√≥n de programas.

Margaret House, R.N., B.S.N.
Maggie es una enfermera adjunta en la DCP con m√°s de 30 a√Īos de experiencia en enfermer√≠a oncol√≥gica y ensayos cl√≠nicos.

Centros de Asociación de ULACNet

ULACNet Partnership Centers: CAMPO, ROCCHHA, Colaboración Evita

Português

Bem-vindo a ULACNet Update, onde compartilharemos atualiza√ß√Ķes program√°ticas e de pesquisa para a US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet - Rede de Pesquisa Clinicas para a Preven√ß√£o de C√Ęncer HIV/HPV dos EUA-Am√©rica Latina-Caribe)!

ULACNet √© uma rede internacional de pesquisa colaborativa, com organiza√ß√Ķes parceiras nos EUA, Am√©rica Latina e Caribe, focada no desenvolvimento de evid√™ncias de preven√ß√£o do c√Ęncer relacionado ao papilomav√≠rus humano (HPV) em pessoas que vivem com o v√≠rus da imunodefici√™ncia humana (HIV).

Os ensaios cl√≠nicos ULACNet exploram quest√Ķes de investiga√ß√£o em tr√™s √°reas-chave:

  • otimiza√ß√£o da dosagem, do fornecimento e avalia√ß√£o de novas indica√ß√Ķes para vacinas profil√°ticas contra o HPV;
  • avaliar novos biomarcadores e tecnologias para melhorar a precis√£o do rastreio e triagem dos c√Ęnceres cervical e anogenital; e
  • avalia√ß√£o de novos tratamentos n√£o excisionais para les√Ķes pr√©-cancerosas relacionadas com o HPV.

Esperamos que a pesquisa desta rede influencie o desenvolvimento de diretrizes de pr√°tica cl√≠nica para a melhora dos cuidados preventivos e a redu√ß√£o do fardo dos c√Ęnceres relacionados ao HPV em pessoas que vivem com HIV.

Equipa de Gest√£o

Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Vik √© Diretor do Programa ULACNet e vice-chefe do grupo de Pesquisa de C√Ęncer de Mama e Ginecol√≥gico que supervisiona a investiga√ß√£o cl√≠nica de preven√ß√£o do c√Ęncer cervical e outros c√Ęnceres relacionados com o papilomav√≠rus humano (HPV).

Silvina Frech, Ph.D, M.S.
Silvina √© Diretora do Programa do Grupo de Pesquisa de C√Ęncer de Mama e Ginecol√≥gico, com mais de 20 anos de experi√™ncia em pesquisa e controle do c√Ęncer em pa√≠ses de baixa e m√©dia renda.

Brandy Heckman-Stoddard, Ph.D., M.P.H.
Brandy √© o chefe do grupo do DCP de pesquisa dos c√Ęnceres de mama e ginecol√≥gico.

Emma Brofsky, M.S.P.H.
Emma √© uma analista de programas cient√≠ficos com uma forte forma√ß√£o em sa√ļde p√ļblica e gest√£o de programas.

Margaret House, R.N., B.S.N.
Maggie é consultora de enfermagem do DCP com mais de 30 anos de experiência em oncologia e ensaios clínicos.

Centros Parceiros da ULACNet

Centros Parceiros da ULACNet

For more information on ULACNet, please contact ULACNet@mail.nih.gov.